SYDNEY, Oct. 1, 2026 /PRNewswire/ — IMG (International Medical Group) is excited to announce the successful completion of its acquisition of …
Casio to Release MR-G Crafted in Blue Sapphire Crystal
Featuring Multi-Component Structure with Screwless Design TOKYO, Oct. 1, 2026 /PRNewswire/ — Casio Computer Co., Ltd. announces the release of …
Project Tapestry Gains Momentum for Sovereign AI During UN General Assembly Week
First Technical Milestones Achieved Alongside Expanded Collaborations with Vietnam and India NEW YORK, Oct. 1, 2026 /PRNewswire/ — The AI …
THE HEADLINER PROJECT launched today with Will Smith, bringing the genuine artistry of a Hollywood icon to ambitious companies across six markets.
Put a Hollywood Star in Your Company’s Advertising TOKYO, Oct. 1, 2026 /PRNewswire/ — Eclairer Inc. today officially launched THE …
Frost & Sullivan Launches Top Performers Program to Spotlight Overlooked, High-Performing College Programs
New program combines independent market analysis, program-level insights, and ongoing visibility support to help institutions strengthen student recruitment and help …
Arbitral Tribunal Reaffirms Korea’s Liability to Elliott for Corrupt Intervention in 2015 Samsung Merger
Elliott awarded approximately US $113 million Elliott hopes the ROK will finally honor the Award as interest continues to accrue, …
ROYAL CARIBBEAN REVEALS 2028 SUMMER LINEUP OF ALASKA VACATIONS
Vacationers are in for unforgettable adventures to The Last Frontier with 7-night vacations across four Royal Caribbean ships and extended …
CJ 4DPLEX and Cinemark Announce Expansion of 20 New SCREENX Locations Across the U.S. and Latin America
Agreement adds 17 SCREENX auditoriums in the U.S. and three in South and Central America Six U.S. locations slated to …
Crisis • Resilience • Evolution — Building a Tourism Economy for a Shared Future
The 12th Global Tourism Economy Forum • Macao 2026 To be held on 15 to 17 October MACAO, Sept. 30, …
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The …